MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer

Adoptive immunotherapy using cytokine-induced killer (CIK) cells is a promising cancer treatment, but its efficacy is restricted by various factors, including the accumulation of myeloid-derived suppressor cells (MDSCs). In this study, we determine whether chemotherapeutic drugs that reduce MDSC lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zibing, Liu, Yuqing, Zhang, Yong, Shang, Yiman, Gao, Quanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826241/
https://www.ncbi.nlm.nih.gov/pubmed/26716894
http://dx.doi.org/10.18632/oncotarget.6734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826241/
https://www.ncbi.nlm.nih.gov/pubmed/26716894
http://dx.doi.org/10.18632/oncotarget.6734

Ejemplares similares